We are live on ! Find out more
GMDA

Gamida Cell Ltd. Ordinary Shares

Delisted

GMDA was delisted on the 5th of April, 2024.

62 hedge funds and large institutions have $38.3M invested in Gamida Cell Ltd. Ordinary Shares in 2022 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 17 increasing their positions, 12 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

331% more call options, than puts

Call options by funds: $392K | Put options by funds: $91K

83% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 6

48% more capital invested

Capital invested by funds: $25.9M → $38.3M (+$12.4M)

42% more repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 12

9% more funds holding

Funds holding: 5762 (+5)

Holders
62
Holders Change
+5
Holders Change %
+8.77%
% of All Funds
1.07%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
11
Increased
17
Reduced
12
Closed
6
Calls
$392K
Puts
$91K
Net Calls
+$301K
Net Calls Change
+$395K

GMDA Hedge Fund Activity: Q3 2022 in Review

62 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Gamida Cell Ltd. Ordinary Shares (GMDA) for Q3 2022, worth a combined $38.3M — up 48% from $25.9M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new GMDA positions and 6 closed out — a net gain of 5 holders — while 17 added to existing stakes and 12 trimmed.

The largest buyer was Meitav Investment House, adding an estimated $7.35M. The largest seller was Highbridge Capital Management, exiting entirely with an estimated $2.12M sold.

  • 62 institutional investors held Gamida Cell Ltd. Ordinary Shares (GMDA) as of Q3 2022, up from 57 in Q2 2022.
  • Funds reported $38.3M of Gamida Cell Ltd. Ordinary Shares stock for Q3 2022, up 48% quarter-over-quarter.
  • 11 funds opened new Gamida Cell Ltd. Ordinary Shares positions in Q3 2022 and 6 closed out, a net change of +5 holders.
  • The largest Gamida Cell Ltd. Ordinary Shares buyer in Q3 2022 was Meitav Investment House, an estimated $7.35M added.
  • The largest Gamida Cell Ltd. Ordinary Shares seller in Q3 2022 was Highbridge Capital Management, an estimated $2.12M sold.

Based on aggregated 13F filings for Q3 2022.